Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary Bypass

NCT00131040 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2015-05-28

No results posted yet for this study

Summary

The purpose of this study was to see if the heart-lung machine involved in cardiac surgery increases the movement of activated white blood cells from the bloodstream into the patient's tissues and also to see if aprotinin usage during surgery reduces this effect.

Conditions

  • Ischemic Heart Disease
  • Angina Pectoris

Interventions

DRUG

Aprotinin

Sponsors & Collaborators

  • British Heart Foundation

    collaborator OTHER
  • Imperial College London

    lead OTHER

Principal Investigators

  • Kenneth M Taylor, MD, FRCS · Hammersmith Hospital Campus, Imperial College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-01-31
Completion
2005-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00131040 on ClinicalTrials.gov